Evicenter
Xtandi (enzalutamide) in Castration-resistant prostate cancer
Manufacturer
Astellas Pharma US, Inc.; Pfizer Inc.
Prescribing information
Xtandi (opens in a new tab)
Questions
20
Last updated

All questions

Guidelines: Xtandi (enzalutamide) in castration-resistant prostate cancer

1 question · 2 sources

Guidelines

Do NCCN and AUA guidelines recommend Xtandi (enzalutamide)?

Note: The guidelines page presents the recommendation for each disease state in a graphic whose text was not captured. The footnotes quoted here qualify entries of that graphic; the capture does not show which entry each footnote marks. The page was captured November 13, 2026.